FDA Advisory Committee to Review Peptide Restrictions Underway
NBC News

FDA Advisory Committee to Review Peptide Restrictions Underway

· 12 hours ago

Peptides are often being promoted by wellness influencers and podcasters as treatments for everything from injuries and aging and now an FDA panel is meeting to discuss whether to loosen restrictions and make them easier to get. But critics say there's not enough data on safety and efficacy. NBC’s m...

Peptides are often being promoted by wellness influencers and podcasters as treatments for everything from injuries and aging and now an FDA panel is meeting to discuss whether to loosen restrictions and make them easier to get. But critics say there's not enough data on safety and efficacy. NBC’s medical contributor Natalie Azar joins TODAY to break down the seven peptides being discussed and how effective they are.

FDA panel recommends easing restrictions on several peptides
NBC News

FDA panel recommends easing restrictions on several peptides

A Food and Drug Administration advisory committee narrowly voted in favor of loosening restrictions on peptides over strong objections from agency career scientists. Throughout the daylong meeting, FDA scientists detailed a lack of evidence supporting the use of the peptides along with safety concer...

FDA panel recommends controversial treatments
NBC News

FDA panel recommends controversial treatments

A controversial new FDA panel recommendation could affect the sale of peptides—popular treatments marketed for benefits ranging from muscle growth to weight loss. NBC News’ Anne Thompson explains why not everyone thinks they’re a good idea.

Mounting frustrations over Wisconsin police shooting
NBC News

Mounting frustrations over Wisconsin police shooting

Authorities say Corey Ruiz was shot and killed by a police officer in Madison, Wisconsin. Multiple videos capture the incident from different angles. After a chase and a struggle, police say Ruiz pulled out a knife. NBC News’ Shaquille Brewster reports from the scene.

← Back to all news

We use cookies to improve your experience and serve personalized ads. By continuing, you agree to our Cookie Policy and Privacy Policy.